2026. Head and Neck Atopic Dermatitis: Therapeutic Response After Switching to Upadacitinib in Moderate-to-Severe Atopic Dermatitis Patients Who Had Inadequate Response to Dupilumab. SKIN The Journal of Cutaneous Medicine. 10, 2 (Mar. 2026), s740. DOI:https://doi.org/10.25251/ztj3rn69.